Compounds > acetylleucyl-leucyl-norleucinal
Page last updated: 2024-09-02

acetylleucyl-leucyl-norleucinal and threonine

acetylleucyl-leucyl-norleucinal has been researched along with threonine in 4 studies

Compound Research Comparison

Studies
(acetylleucyl-leucyl-norleucinal)		Trials
(acetylleucyl-leucyl-norleucinal)		Recent Studies (post-2010)
(acetylleucyl-leucyl-norleucinal)		Studies
(threonine)		Trials
(threonine)		Recent Studies (post-2010) (threonine)
32105310,383982,176

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baldin, V; Cans, C; Ducommun, B; Knibiehler, M1
Desai, NB; Dmitrovsky, E; Dragnev, KH; Freemantle, SJ; Ma, Y; Murphy, B; Petty, WJ; Pitha-Rowe, I; Rendi, M; Sekula, D; Sporn, MB; Suh, N1
Moir, RD; Myre, MA; Tanzi, RE; Tesco, G; Wasco, W; Washicosky, K1
Minchin, RF; Mitchell, DJ1

Other Studies

4 other study(ies) available for acetylleucyl-leucyl-norleucinal and threonine

ArticleYear
Phosphorylation of human CDC25B phosphatase by CDK1-cyclin A triggers its proteasome-dependent degradation.
    The Journal of biological chemistry, 1997, Dec-26, Volume: 272, Issue:52

    Topics: Calpain; CDC2 Protein Kinase; cdc25 Phosphatases; Cell Cycle; Cell Cycle Proteins; Cyclin A; Cysteine Endopeptidases; HeLa Cells; Humans; Leupeptins; Multienzyme Complexes; Phosphoprotein Phosphatases; Phosphorylation; Proteasome Endopeptidase Complex; Threonine; Tyrosine

1997
Specific chemopreventive agents trigger proteasomal degradation of G1 cyclins: implications for combination therapy.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Apr-01, Volume: 10, Issue:7

    Topics: Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Bronchi; Cell Culture Techniques; Cell Division; Cell Line; Cyclin D1; Cyclin E; Cyclin G; Cyclin G1; Cyclins; DNA Damage; Dose-Response Relationship, Drug; Epithelial Cells; G1 Phase; Humans; Immunoblotting; Leupeptins; Mutation; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Retinoids; Reverse Transcriptase Polymerase Chain Reaction; Threonine; Transcription, Genetic; Transfection; Tretinoin

2004
Reduced amyloidogenic processing of the amyloid beta-protein precursor by the small-molecule Differentiation Inducing Factor-1.
    Cellular signalling, 2009, Volume: 21, Issue:4

    Topics: Acetylcysteine; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Benzazepines; Cell Line; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; Cyclin D1; Fibroblasts; Glioma; Hexanones; Humans; Hydrocarbons, Chlorinated; Indoles; Leupeptins; Mice; Peptide Fragments; Proteasome Inhibitors; Purines; Recombinant Fusion Proteins; Roscovitine; Threonine

2009
Cytosolic Aryl sulfotransferase 4A1 interacts with the peptidyl prolyl cis-trans isomerase Pin1.
    Molecular pharmacology, 2009, Volume: 76, Issue:2

    Topics: Amino Acid Motifs; Amino Acid Sequence; Binding Sites; Calpain; Cysteine Proteinase Inhibitors; Cytosol; Escherichia coli; Escherichia coli Proteins; Glutathione Transferase; Half-Life; HeLa Cells; Humans; Leupeptins; Molecular Sequence Data; NIMA-Interacting Peptidylprolyl Isomerase; Okadaic Acid; Peptidylprolyl Isomerase; Phosphorylation; Proline; Protein Binding; Recombinant Proteins; Serine; Sulfotransferases; Threonine; Transfection; Two-Hybrid System Techniques

2009